National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1277 out of 2,175

Result pages: prev   1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286   next


VAERS ID: 1245691 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-22
Onset:2021-01-26
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM04777 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Epilepsy, General physical health deterioration, SARS-CoV-2 test, Seizure
SMQs:, Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-10
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210122; Test Name: covid-19 test; Test Result: Negative ; Test Date: 20210126; Test Name: covid-19 test; Test Result: Positive
CDC Split Type: BEPFIZER INC2021420662

Write-up: inaugural seizure; Seizures (generalized); General physical health deterioration; covid smear positive 26Jan; This is a spontaneous report from a contactable pharmacist downloaded from the regulatory authority BE-FAMHP-DHH-N2021-78170. A 79-years-old female patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 22Jan2021 (Batch/Lot Number: EM04777) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced inaugural seizure, convulsions 2 hours after vaccine and emergency room admission with outcome of fatal, general physical health deterioration with outcome of fatal, sars-cov-2 test: positive with outcome of unknown. The patient was hospitalized for inaugural seizure (epilepsy) from 22Jan2021 to an unknown date. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 22Jan2021, sars-cov-2 test: positive on 26Jan2021. The patient died on 10Feb2021. It was not reported if an autopsy was performed. Reporter''s comment: 2 hours after vaccine seizure epilepsy admission emergency room covid smear negative 22Jan -$g transfer to neurology department, initiation of depakine with stabilization of the state of consciousness but clear general deterioration, planned return to nursing home -$g covid smear positive 26Jan-$g transfer to hospital covid unit - performance deteriorated significantly on 03Feb - call from the rest home on 04Feb for DEG -$g readmission to hospital -$g status epilepticus, 2nd then 3rd line of unsuccessful treatment Passage to palliative care -$g death on 10Feb. No follow-up attempts possible. No further information expected.; Reporter''s Comments: Summary of Reporter Comment: 2 hours after vaccine, seizure epilepsy admission emergency room covid smear negative 22Jan -$g initiation of depakine with stabilization of the state of consciousness but clear general deterioration, covid smear positive 26Jan, transfer to hospital covid unit - performance deteriorated significantly on 03Feb - call from the rest home on 04Feb for DEG, readmission to hospital, status epilepticus, 2nd then 3rd line of unsuccessful treatment, death on 10Feb; Reported Cause(s) of Death: inaugural seizure; Seizures (generalized); General physical health deterioration


VAERS ID: 1245719 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-02
Onset:2021-02-04
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9788 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Brain oedema, C-reactive protein, Cardiac failure, Cough, Decreased appetite, Dyspnoea, Fatigue, Gait disturbance, Influenza like illness, Myalgia, Oxygen saturation, Oxygen saturation decreased, Pyrexia, Respiratory failure, Sputum discoloured, X-ray
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Parkinson-like events (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Hyponatraemia/SIADH (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Hypokalaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-02-16
   Days after onset: 12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: AMPRILAN; PRADAXA; OMEPRAZOL; ATORVASTATIN; EBRANTIL [URAPIDIL]; CORDARONE; HYDROCHLOROTHIAZID; FURORESE [FUROSEMIDE]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Bentall procedure (replacement of the aortic valve with bioprothesis); Cardiac valve disease (valve defects); Hypercholesterolemia; Hypertension arterial; Ischemic heart disease; Comments: no allergies
Allergies:
Diagnostic Lab Data: Test Date: 20210207; Test Name: Body temperature; Result Unstructured Data: Test Result:39.5 - 39 Centigrade; Test Date: 202102; Test Name: C-reactive protein; Result Unstructured Data: Test Result:<=150 mg/l; Test Date: 20210204; Test Name: O2 saturation; Test Result: 40 %; Comments: during the night; Test Date: 20210204; Test Name: Oxygen saturation; Result Unstructured Data: Test Result:80-90 %; Comments: during the day; Test Date: 202102; Test Name: X-ray; Result Unstructured Data: Test Result:intersticial inflammatory process; Comments: intersticial inflammatory process in middle and lower lung field on the right side and in middle lung field on the left side
CDC Split Type: CZPFIZER INC2021420590

Write-up: Hypoxic heart failure caused by cerebral edema; Respiratory failure; Hypoxic heart failure caused by cerebral edema; fever, 38.5 - 39 C; Muscles pain, fatigue; low O2 saturation, During the night even about 40%; Then difficult expectoration of dark brown sputum; walking difficulties up the stairs, then it aggravated even on level ground.; Muscles pain, fatigue; Muscles pain, fatigue; Anorexia; cough; Stuffiness; This is as spontaneous report received from a contactable Other Health Professional downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is CZ-CZSUKL-21003954. A 73-years-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 02Feb2021 (Batch/Lot Number: EK9788) as single dose for covid-19 immunisation. Medical history included Ischemic heart disease, cardiac valve disease (valve defects), Hypertension arterial, bentall procedure, replacement of the aortic valve with bioprothesis , hypercholesterolaemia all not ongoing. Concomitant medication(s) included ramipril (AMPRILAN) oral at 10 mg; dabigatran etexilate mesilate (PRADAXA) oral at 300mg; omeprazole (OMEPRAZOL) oral at 20mg; atorvastatin (ATORVASTATIN) oral at 20mg; urapidil (EBRANTIL [URAPIDIL oral at 60mg; amiodarone hydrochloride (CORDARONE) oral at 100mg; hydrochlorothiazide, furosemide (FURORESE [FUROSEMIDE oral at 125mg, all long-term medication. The patient experienced hypoxic heart failure caused by cerebral edema (death, hospitalization, medically significant, life threatening) on 16Feb2021 , respiratory failure (death, hospitalization, medically significant, life threatening) on 16Feb2021 with outcome of fatal, anorexia (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of unknown, cough (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of not recovered, stuffiness (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of not recovered, fever, 38.5 - 39 c (hospitalization, medically significant, life threatening) on 07Feb2021 with outcome of not recovered, muscles pain, fatigue (influenza like illness) (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of not recovered, low o2 saturation, during the night even about 40% (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of unknown, then difficult expectoration of dark brown sputum (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of not recovered, walking difficulties up the stairs, then it aggravated even on level ground (hospitalization, medically significant, life threatening) on 04Feb2021 with outcome of not recovered. The patient underwent lab tests and procedures which included body temperature: 39.5 - 39 centigrade on 07Feb2021, c-reactive protein: <=150 mg/l on Feb2021, oxygen saturation: 40 % on 04Feb2021 during the night, oxygen saturation: 80-90 % on 04Feb2021 during the day, x-ray: intersticial inflammatory process in middle and lower lung field on the right side and in middle lung field on the left side on Feb2021. The patient died on 16Feb2021. The cause of death was hypoxic cardiac failure cause by brain oedema, which developed due to respiratory failure. An autopsy was not performed. The clinical course was reported as follows: Health Care Professional report: A 73-year-old male patient experienced following adverse reaction after the administration of the 1st dose of COMIRNATY vaccine (02Feb2021): cough, fever 38.5 - 39 C, dyspnoe, low O2 saturation, inappetence. At first it was dry cough - treated with Erdomed and Klacid. Then difficult expectoration of dark brown sputum. Fever 38.5 - 39 C, it was treated with antipyretics and cold poultice. Exertional dyspnoe, which getting worse. First walking difficulties up the stairs, then it aggravated even on level ground. On the bed he was almost sitting. O2 saturation 80-90%. During the night even about 40%. Inappetence. The reaction was fatal. The day of death - 16Feb2021. Autopsy was not done. The cause of death was hypoxic cardiac failure cause by brain oedema, which developed due to respiratory failure. Medical history: no allergies, ischaemic heart disease, valve defects, state after surgery Bentall - replacement of the aortic valve with bioprothesis, arterial hypertension, hypercholesterolaemia. Concomitant medication: Omeprazol, Cordarone, Pradaxa, Hydrochlothiazid, Amprilan, KCl, Furorese, Atorvastatin, Ebrantil. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Hypoxic heart failure due to brain oedema.; Respiratory failure; Hypoxic heart failure due to brain oedema.


VAERS ID: 1245722 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-10
Onset:2021-04-13
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Cardiogenic shock
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-13
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021431537

Write-up: Asystole; Cardiogenic shock; This is a spontaneous report from a non-contactable physician downloaded from the Medicines Agency (MA) Database-WEB, Regulatory Authority number DE-PEI-202100035451. An 80-year-old male patient received BNT162B2 (COMIRNATY, solution for injection, Lot number not provided), via an unspecified route of administration, on 10Apr2021 at 0.3 mL single for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. On 13Apr2021, the patient experienced asystole and cardiogenic shock, both events serious because requiring hospitalization and as life-threatening condition. Lastly, the patient died due asystole and cardiogenic shock. However, cause of death was also reported unknown. An autopsy was not performed. Sender Comment: Dissection not wanted by family. Causal relationship between the adverse events and the administration of vaccine was assessed as "Unclassifiable" by the PEI. Information about lot/batch number cannot be obtained. No further information expected; Reported Cause(s) of Death: Unknown cause of death; asystole; cardiogenic shock


VAERS ID: 1245738 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-27
Onset:2021-03-29
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Septic shock, Vasoplegia syndrome
SMQs:, Toxic-septic shock conditions (narrow), Sepsis (narrow), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-30
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes mellitus; Hypertension; Obesity
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESPFIZER INC2021431625

Write-up: Septic shock; Vasoplegic shock; This is a spontaneous report from a contactable Physician downloaded from the Agency Regulatory Authority-WEB ES-AEMPS-825390 An 80-year-old female patient received the second dose of BNT162b2 (COMIRNATY, Batch/Lot number unknown) via an unspecified route of administration on 27Mar2021 at 0.3ml single for COVID-19 immunisation. Relevant medical history included diabetes mellitus, hypertension and obesity. The patient had no history of COVID-19. Concomitant medications were not reported. On 29Mar2021, two days after the second dose of vaccine the patient presented septic/vasoplegic shock. The correlation with the drug was not clear, but there was suspicion that it was a bacterial sepsis (gram-negative bacteria or pneumococcus) of unclear origin. Severe sepsis, with refractory vasoplegia and sepsis cardiomyopathy. No additional information could have been obtained. The event was serious as causing hospitalization and fatal. The patient died on 30Mar2021. It was unknown whether an autopsy was performed. No follow-up attempts possible. No information expected. Batch number cannot be obtained.; Reported Cause(s) of Death: Vasoplegic shock; septic shock (10040070)


VAERS ID: 1245739 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-05
Onset:2021-04-06
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2239 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Biopsy endometrium, Cerebral haemorrhage, Computerised tomogram, Computerised tomogram head, SARS-CoV-2 test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-10
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: SINTROM; LOSARTAN HCT; FUROSEMIDE; SPIRONOLACTONE; DISTRANEURINE [CLOMETHIAZOLE]; LACTULOSE
Current Illness: Atrial fibrillation (Treated with oral anticoagulant therapy with INR good control); Brain lesion (Residual to previous ischaemic pathology and Leukoaraiosis in CT 2009); Cerebral atrophy (Significant cerebral atrophy with severe degenerative cognitive impairment); Chronic kidney disease stage 4; Cognitive impairment (Severe degenerative. With significant cerebral atrophy + hypodense lesion R basal ganglia); Dyslipidemia; Euthyroid goiter; Heart failure; Hypertension arterial; Obesity
Preexisting Conditions: Medical History/Concurrent Conditions: Leukoaraiosis (In CT scan); Metrorrhagia (Clear cells and hobnail suspicious of malignancy); Middle cerebral artery stroke (Of cardioembolic origin); Neoplasm malignant (Clear cells and hobnail suspicious of malignancy (found after metrorrhagia))
Allergies:
Diagnostic Lab Data: Test Date: 2018; Test Name: Endometrial biopsy; Result Unstructured Data: Test Result:Clear cells and hobnail suspicious of malignancy; Test Date: 2009; Test Name: CT scan; Result Unstructured Data: Test Result:Leukoaraiosis; Test Date: 202104; Test Name: CT brain scan; Result Unstructured Data: Test Result:Parenchymal haemorrhage R frontal lobe convexity; Comments: With significant perilesional oedema and mass effect on neighbouring structures, collapse of the right lateral ventricle and 5 mm midline shift. No intraventricular haemorrhage; Test Date: 202104; Test Name: SARS-Cov-2 PCR test; Test Result: Negative
CDC Split Type: ESPFIZER INC2021431645

Write-up: Cerebral hemorrhage; This is as spontaneous report received from a contactable physician downloaded from the regulatory authority. The regulatory authority report number is ES-AEMPS-825476. A 91-year-old female patient received BNT162b2 (COMIRNATY), dose 1, via an unspecified route of administration, on 05Apr2021 (Batch/Lot Number: EW2239), as single dose, for COVID-19 immunisation. Medical history included ongoing arterial hypertension, ongoing obesity, ongoing dyslipidaemia, severe degenerative cognitive impairment with significant cerebral atrophy and hypodense lesion in right basal ganglia residual to previous ischaemic pathology and Leukoaraiosis showed in a CT in 2009, ongoing atrial fibrillation treated with oral anticoagulant therapy with INR good control, ongoing herat failure, ongoing stage IV chronic kidney disease, left middle cerebral artery stroke of cardioembolic origin in 2007, euthyroid multinodular goiter, metrorrhagia in 2018 due to which an endometrial biopsy and patological anatomy was performed showing clear cells and hobnail suspicious of malignancy. It was unknown if the patient ever experienced COVID-19. Concomitant medications included acenocoumarol (SINTROM), hydrochlorothiazide/ losartan potassium (LOSARTAN HCT, 100/25mg), furosemide 40 mg, spironolactone 25 mg, clomethiazole (DISTRANEURINE), and lactulose. On 06Apr2021, the patient started presenting decreased level of consciousness, refusal to eat, and fever. There was no ''mobilisation'' (as reported) of the left upper limb (they were not able to say since when). On 09Apr2021, the patient she was taken to the emergency department for general malaise. There was no recent cranioencephalic traumatism. There were no other symptoms regarding any other organs. A CT scan of the brain was done that showed parenchymal haemorrhage in the convexity of the right frontal lobe, with significant perilesional oedema and mass effect on neighbouring structures, with collapse of the right lateral ventricle and 5 mm midline shift. No intraventricular haemorrhage was observed. A PCR for SARS-CoV-2 was negative. The patient was hospitalized and died due to cerebral hemorrhage on 10Apr2021. It was not reported if an autopsy was performed. No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Cerebral hemorrhage


VAERS ID: 1245740 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-02
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2239 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Headache, SARS-CoV-2 test, Ultrasound abdomen, X-ray
SMQs:, COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: VALSARTAN; PARACETAMOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hearing aid wearer; Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 20210217; Test Name: Ag test; Result Unstructured Data: Test Result:Positive; Test Date: 20210205; Test Name: COVID-19 PCR test; Test Result: Positive ; Test Date: 20210207; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:Covid-19; Test Date: 20210217; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:not been confirmed; Test Date: 20210205; Test Name: abdominal ultrasound; Result Unstructured Data: Test Result:unknown results; Test Date: 20210205; Test Name: X-ray; Result Unstructured Data: Test Result:unknown results
CDC Split Type: ESPFIZER INC2021436223

Write-up: Unbearable headache. Death; This is a spontaneous report from a contactable consumer downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number for the first report is ES-AEMPS-793019. This consumer reported different events for both doses of Comirnaty for the same patient. This is the second of two reports. A 93-year-old female patient received the second dose of bnt162b2 (COMIRNATY), via an unspecified route of administration, administered in Arm on 01Apr2021 (Batch/Lot Number: EW2239) as single dose for covid-19 immunisation. Medical history included hypertension from an unknown date, hearing aid user from an unknown date. Concomitant medication(s) included valsartan (VALSARTAN) taken for hypertension, start and stop date were not reported; paracetamol (PARACETAMOL) taken for an unspecified indication, start and stop date were not reported. The patient previously took cyanocobalamin, and deltius. Patient had first dose of Cominarty and experienced covid-19 pneumonia on 07Feb2021 and on 17Feb2021 hypoacusis, Clostridium difficile infection and retention of urine. The patient experienced "unbearable headache. Death" on 02Apr2021 and was admitted to hospital. The patient died on 05Apr2021. It was reported in a mail received that they forced him to take the dose, which he did not want, and neither for the 1st nor the 2nd dose did he sign any consent, nor was he at any time informed of the possible side effects or adverse effects. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 17Feb2021, positive on 05Feb2021, covid-19 on 07Feb2021, not been confirmed on 17Feb2021, on 05Feb2021 ultrasound abdomen and x-ray both with unknown results. Outcome of event death was fatal. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number already obtained.; Sender''s Comments: Linked Report(s) : ES-PFIZER INC-2021333380 same patient, different event after 2nd dose of Comirnaty; Reported Cause(s) of Death: Unbearable headache. Death


VAERS ID: 1245741 (history)  
Form: Version 2.0  
Age: 73.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-31
Onset:2021-03-31
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Circulatory collapse, Contusion, Headache, Pain in extremity, Resuscitation, Ventricular fibrillation, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Arrhythmia related investigations, signs and symptoms (broad), Ventricular tachyarrhythmias (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Acute central respiratory depression (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypersensitivity (narrow), Respiratory failure (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypercholesterolemia
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIPFIZER INC2021431583

Write-up: Ventricular fibrillation; Contusion; Cardiac arrest; Circulatory collapse; Cardiopulmonary resuscitation; Vomiting; Pain in arm; Headache; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB, regulatory authority number FI-FIMEA-20211807. A 73-year-old female patient received BNT162B2 (Pfizer vaccine solution for injection), intramuscular on 31Mar2021 (Batch/Lot Number: UNKNOWN) as SINGLE DOSE for covid-19 immunisation. The patient''s medical history hypercholesterolemia without medication. Concomitant medications were not reported. The patient started experiencing experienced pain in arm and headache, for which she took paracetamol on 31Mar2021. The patient slept normally and on 01Apr2021 ate breakfast and thereafter went to toilet. She didn''t complain any symptoms in the morning. Since she stayed in the toilet longer than normally, husband went to look for her. She was walking from toilet to the front door. On the way collapsed on her stomach and vomited. Ambulance was called. Resuscitation was started, laryngeal mask was put on, intraosseous access in left tibia. On monitor first coarse ventricular fibrillation, defibrillated once, after that cardiac arrest. The patient was pronounced dead and resuscitation was stopped. In the external inspection, vomit in both nostrils, at the corner of the mouth and also a bit in the tube of the laryngeal mask. On the bridge of nose a small contusion, 1 x 0,5 cm, probably caused by falling to the metallic doorstep or already in the toilet. Beginning postmortem lividity, otherwise skin normal. Sent to medicolegal autopsy. Reported adverse events were contusion, ventricular fibrillation, cardiac arrest, headache, Circulatory collapse, Pain in arm, Cardiopulmonary resuscitation and Vomiting, all assessed as fatal. Information about lot/batch number cannot be obtained. No further information expected; Reported Cause(s) of Death: contusion; pain in extremity; headache; ventricular fibrillation; Vomiting; cardiac arrest; Circulatory collapse; Cardiopulmonary resuscitation


VAERS ID: 1245743 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-23
Onset:2021-03-01
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM6950 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Chills, Death, Fatigue, Influenza like illness, Pyrexia, SARS-CoV-2 test, Thirst
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-07
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Allergy to animal; Alzheimer''s disease; Pollen allergy
Allergies:
Diagnostic Lab Data: Test Name: covid-19 test; Test Result: Negative
CDC Split Type: FRPFIZER INC2021431548

Write-up: Death NOS; Influenza like illness; chills; great fatigue; low fever; thirst; This is as spontaneous report received from a contactable consumer downloaded from a regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-BX20213108, Safety report unique identifier FR-AFSSAPS-2021038133. A 74-year-old male patient received the second dose of bnt162b2 (COMIRNATY), intramuscular on 23Feb2021 (Batch/Lot Number: EM6950) as single dose for COVID-19 immunisation. The patient received the first dose of Comirnaty on 03Feb2021. Medical history included allergy to animal, pollen allergy and Alzheimer''s disease. The patient was living in a in nursing homes. The patient''s concomitant medications were not reported. On sixth day after the 2nd dose, on 01Mar2021, the patient presented influenza-like illness, chills, great fatigue, thirst and low fever. The patient was tested on an unspecified date and he did not have COVID-19. On the twelfth, day after the 2nd dose, patient found in his bed died on 07Mar2021 in the morning, died during the night of 06Mar2021 to 07Mar2021. It was not reported if an autopsy was performed. The cause of death was reported as sudden death. The outcome of other events was unknown. Information about lot/batch number cannot be obtained. No further information expected.; Reported Cause(s) of Death: sudden death


VAERS ID: 1245762 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-10
Onset:2021-02-10
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19 immunisation, Cardiac arrest, Cerebral thrombosis, Seizure
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Ischaemic central nervous system vascular conditions (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Hypoglycaemia (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 48
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetic nephropathy
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021424802

Write-up: seizures; cardiac arrest; COVID-19 immunization; cerebral sinus thrombosis; This is a spontaneous report from a contactable physician. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-EYC 00248005, Safety Report Unique Identifier GB-MHRA-ADR 25152625. A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 10Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 vaccination. Medical history included diabetic nephropathy. The patient''s concomitant medications were not reported. The patient experienced COVID-19 immunization on 10Feb2021. Clinical course: This patient received Pfizer COVID-19 vaccination on 10Feb2021. According to information from daughter the deceased was poorly since the vaccination. However, he had diabetic nephropathy requiring dialysis. He developed seizures 4x on 28Mar2021 and went to cardiac arrest in Mar2021. During CPR he aspirated and remined in ITU. He died on 31Mar2021. Reporter performed the post-mortem and diagnosed cerebral sinus thrombosis (CST) in 2021. Histology was pending. It was likely that the CST was not related to vaccination due to long interval between vaccination and CST. The patient died on 31Mar2021. The case was reported as serious (death). Outcome of events was fatal. No follow-up attempts are possible, information on lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19 immunization; seizures; cardiac arrest; Autopsy-determined Cause(s) of Death: cerebral sinus thrombosis


VAERS ID: 1245828 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-21
Onset:2020-12-27
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Magnetic resonance imaging, SARS-CoV-2 test
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-04
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Disease risk factor (high risk of blood clotting); Hospitalization
Allergies:
Diagnostic Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:confirmed severity and damage caused by blood clot; Test Name: COVID-19 virus test; Test Result: Negative
CDC Split Type: GBPFIZER INC2021422359

Write-up: Stroke; blood clot on the base of his brain; This is a spontaneous report from a contactable consumer. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202104071745142200, Safety Report Unique GB-MHRA-ADR 25107985 An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, also reported as Astra Zeneca vaccine), dose 1 via an unspecified route of administration on 21Dec2020 (Lot Number: EJ0553) as single dose for COVID-19 vaccination. Medical history included patient was discharged from hospital around 10Dec2020, with his discharge notes noting that he was at very high risk of blood clotting (unknown if ongoing) and had been taken off a blood thinning medication (not warfarin) but this was withdrawn when in hospital, about one month before vaccine. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. The patient''s concomitant medications were reported as anticoagulant from Nov2020. The patient experienced clot blood and stroke, both on 27Dec2020 which causing death. He had the Astra Zeneca vaccine around 21Dec2020. He had a stroke/ blood clot on the base of his brain on either the 27Dec or 28Dec. While the clot didn''t immediately cause death, it caused brain death. The patient underwent lab tests and procedures which included magnetic resonance imaging (MRI): confirmed severity and damage caused by blood clot, negative COVID-19 virus test on an unknown date. Patient has not tested positive for COVID-19 since having the vaccine. The patient died on 04Jan2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Thrombosis cerebral; stroke


Result pages: prev   1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1277&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166